Effects of γ-Butyrobetaine and Mildronate on Nitric Oxide Production in Lipopolysaccharide-Treated Rats

Basic and Clinical Pharmacology and Toxicology

Volumn 94, Issue 1, 2004, Pages 46-50

  Sjakste, Nikolajs ^a,b   Baumane, Larisa ^b   Boucher, Jean Luc ^c   Dzintare, Maija ^b   Meirena, Dainuvite ^b   Sjakste, Jelizaveta ^a,b   Lauberte, Lasma ^b   Kalvinsh, Ivars ^b  

^a UNIVERSITY OF LATVIA   (Latvia)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA BUTYROBETAINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MILDRONATE; NITRIC OXIDE; 3 (2,2,2 TRIMETHYLHYDRAZINE)PROPIONATE; 3-(2,2,2-TRIMETHYLHYDRAZINE)PROPIONATE; BETAINE; CARNITINE; DRUG DERIVATIVE; GAMMA-BUTYROBETAINE; IMMUNOLOGICAL ADJUVANT; METHYLHYDRAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; ELECTRON SPIN RESONANCE; HEART; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; TESTIS; ANIMAL; BIOSYNTHESIS; METABOLISM; WISTAR RAT;

ANIMALIA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BETAINE; CARNITINE; LIPOPOLYSACCHARIDES; MALE; METHYLHYDRAZINES; NITRIC OXIDE; RATS; RATS, WISTAR; SEPSIS;

EID: 1642298291     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.pto_940108.x     Document Type: Article

References (19)

1. Akahira, M., A. Hara & Y. Abiko: Effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on myocardial derangements induced by hydrogen peroxide in the isolated perfused rat heart. Fundam. Clin. Pharmacol. 1997, 11, 356-364.
2. Baumane, L., M. Dzintare, L. Zvejniece, D. Meirena, L. Lauberte, V. Sile, I. Kalvinsh & N. Sjakste: Increased synthesis of nitric oxide in rat brain cortex due to halogenated volatile anesthetics confirmed by EPR spectroscopy. Acta Anaesthesiol. Scand. 2002, 46, 378-383.
3. Bergamini, S., C. Rota, R. Canali, M. Stafieri, F. Daneri, A. Bini, F. Giovannini, A. Tomasi & A. Iannone: N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide 2001, 5, 349-360.
4. Bredt, D. S. & H. H. H. W. Schmidt: The citrulline assay. In: Methods in nitric oxide research. Eds.: M. Feelisch and J. Stamler. John Wiley & Sons Ltd., 1996, pp. 249-255.
5. Dambrova, M., E. Liepinsh & I. Kalvinsh: Mildronate. Cardioprotective action through carnitine-lowering effect. Trends Cardiovasc. Med. 2002, 12, 275.
6. Dzintare, M., L. Baumane, D. Meirena, L. Lauberte, I. Kalvinsh & N. Sjakste: Involvement of nitric oxide production in the mild-ronate mechanism of action. Pharmacol. Rev. Commun. 2002, 12, 163-170.
7. Heneka, M. T. & D. L. Feinstein: Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 2001, 114, 8-18.
8. Kirkebøen, K. A. & A. Strand: The role of nitric oxide in sepsis - an overview. Acta Anaesthesiol. Scand. 1999, 43, 273-278.
9. Kleschyov, A., B. Muller, T. Keravis, M.-E. Stoeckel & J.-C. Stoclet: Advenyitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences. Amer. J. Physiol. Heart. Circ. 2000, 279, H2743-H2751.
10. Koeck, T & K. L. Kremser: Carnitine alters nitric oxide synthase activity in fibroblasts depending on the peroxisomal status. Int. J. Biochem. Cell. Biol. 2003, 35, 149-156.
11. Mailman, D., S. Guntuku, M. Bhuiyan & F. Murad: Organ sites of lipopolysaccharide-induced nitric oxide production in the anesthetized rat. Nitric Oxide 2001, 5, 243-251.
12. 2+ with diethylthiocarbamate of N-methyl-D-glucamine as traps of nitric oxide in animal tissues: comparative investigations. Biochim. Biophys. Acta 1997, 1336, 225-234.
13. Papapetropoulos, A., R. D. Rudic & W. C. Sessa: Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc. Res. 1999, 43, 509-520.
14. Shutenko, Zh. V., D. A. Aparneva, D. V. Meirena, A.V. Strump, S.G. Venediktova, R. Ozola, I. Kalvinsh & E. I. Lukevits: Comparative study of the antioxidant activity of gamma-butyrobetaine and its natural and synthetic derivatives in vitro. Eksp. Klin. Farmakol. 1997, 60, 54-57.
15. Shutenko, Zh. V., D. V. Meirena, T. I. Kagan & N. I. Sjakste: Mild-ronate: mechanisms of action, perspectives for correction of pathologies. Khim.-Farmats. Zhurnal. 1995, 29, 13-17. (Review in Russian).
16. Simkhovich, B., Zh. Shutenko, D. Meirena, K. B. Khagi, R. J. Mezhapuke, T. N. Molodchina, I. J. Kalvinsh & E. Lukevics: 3-(2,2,2-Trimethylhydrazinium) propionate (THP) - a novel γ-butyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochem. Pharmacol. 1988, 37, 195-202.
17. Sjakste, N., L. Baumane, D. Meirena, L. Lauberte, M. Dzintare & I. Kalvinsh: Drastic increase in nitric oxide content in rat brain under halothane anesthesia revealed by EPR method. Biochem. Pharmacol. 1999, 58, 1955-1959.
18. Wu, C., J. Zhang, H. Abu-Soud, D. K. Ghosh & D. J. Stuehr: High-level expression of mouse inducible nitric oxide synthase in Escherichia coli requires coexpression with calmodulin. Biochem. Biophys. Res. Communs. 1996, 222, 439-444.
19. Yoshimura, T., H. Yokoyama, S. Fujii, F. Takayama, K. Oikawa & H. Kamada: In vivo EPR detection and imaging of endogenous nitric oxide in lipopolysaccharide-treated mice. Nature Biotechnology. 1996, 14, 992-994.